CloudMargin offers OTC derivatives collateral management
22 August 2013 London
Image: Shutterstock
CloudMargin has created a new cloud-based OTC derivatives collateral management platform for the buy side.
“At a fraction of the cost of traditional technology collateral management platforms, CloudMargin offers a real alternative to the spreadsheets that dominate within OTC derivatives end user firms,” said the firm.
“Until now, much of the buy-side had been priced out of having a dedicated collateral management platform and had no viable alternative to spreadsheets,” said Andy Davies, co-founder and CEO of CloudMargin.
“I am thrilled that CloudMargin’s innovative approach and use of the latest cloud-computing technology means we can offer a full featured, full-cycle collateral and margin management platform that’s well within the reach of even the smallest buy-side firm.”
CloudMargin stores CSA parameters through calculating and issuing margin calls to handling disputes, selecting eligible collateral and instructing market movements.
“At a fraction of the cost of traditional technology collateral management platforms, CloudMargin offers a real alternative to the spreadsheets that dominate within OTC derivatives end user firms,” said the firm.
“Until now, much of the buy-side had been priced out of having a dedicated collateral management platform and had no viable alternative to spreadsheets,” said Andy Davies, co-founder and CEO of CloudMargin.
“I am thrilled that CloudMargin’s innovative approach and use of the latest cloud-computing technology means we can offer a full featured, full-cycle collateral and margin management platform that’s well within the reach of even the smallest buy-side firm.”
CloudMargin stores CSA parameters through calculating and issuing margin calls to handling disputes, selecting eligible collateral and instructing market movements.
NO FEE, NO RISK
100% ON RETURNS If you invest in only one securities finance news source this year, make sure it is your free subscription to Securities Finance Times
100% ON RETURNS If you invest in only one securities finance news source this year, make sure it is your free subscription to Securities Finance Times
